Kyverna Therapeutics Inc. (KYTX)
NASDAQ: KYTX
· Real-Time Price · USD
3.43
0.13 (3.94%)
At close: Aug 20, 2025, 3:59 PM
3.43
0.00%
After-hours: Aug 20, 2025, 04:10 PM EDT
Kyverna Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Net Income | -42.08M | -44.63M | -37.49M | -34.49M | -28.8M | -26.69M | -20.67M | -15.46M | -13.09M | -11.14M | -8.5M |
Depreciation & Amortization | 515K | 501K | 563K | 558K | 530K | 482K | 462K | 438K | 413K | 394K | 374K |
Stock-Based Compensation | 2.52M | 2.16M | 1.38M | 3.41M | 1.28M | 2.28M | 784K | 521K | 447K | 468K | 337K |
Other Working Capital | 6.82M | -5.97M | 5.33M | 186K | 6.51M | -4.91M | -1.97M | 2.86M | n/a | -1.59M | -282K |
Other Non-Cash Items | -1.13M | -758K | -1.55M | 2.85M | -1.59M | 526K | 454K | 4K | 438K | 384K | 419K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 8.23M | -2.18M | 34K | 186K | 4.41M | -1.84M | 1.01M | 3.37M | 528K | -1.48M | -1.31M |
Operating Cash Flow | -31.95M | -44.91M | -37.06M | -27.49M | -24.18M | -25.52M | -18.56M | -11.13M | -11.26M | -11.46M | -8.82M |
Capital Expenditures | n/a | n/a | -532K | -102K | -1.03M | -543K | -334K | -256K | -3K | -28K | -12K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -94.73M | -81.12M | -127.25M | -137.52M | -79.89M | -145.34M | -985K | -53.86M | n/a | n/a | -1.44M |
Sales Maturities Of Investments | 124.1M | 84.59M | 157M | 132.87M | 13M | 23M | 33M | n/a | n/a | 13.68M | 16.6M |
Other Investing Acitivies | -200K | 2.11M | n/a | 5.43M | n/a | -122.34M | 32.02M | n/a | n/a | 13.68M | 15.16M |
Investing Cash Flow | 29.17M | 5.58M | 29.22M | 676K | -67.92M | -122.88M | 31.68M | -54.12M | -3K | 13.65M | 15.15M |
Debt Repayment | -262K | -341K | -247K | -242K | -236K | -231K | -219K | -205K | -189K | -168K | -145K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -387K | n/a | 341.2M | n/a | -333K | -2.89M | -1.22M | 154K | 25.09M | 24K | 43K |
Financial Cash Flow | -649K | -414K | -215K | -152K | -569K | 338.05M | -1.43M | 34.79M | 24.91M | -144K | -102K |
Net Cash Flow | -3.43M | -39.75M | -8.05M | -26.96M | -92.67M | 189.65M | 11.68M | -30.46M | 13.65M | 2.05M | 6.23M |
Free Cash Flow | -32.15M | -44.91M | -37.59M | -27.59M | -25.2M | -26.07M | -18.9M | -11.39M | -11.26M | -11.49M | -8.83M |